Immunology 5 Flashcards
Define rejection with regards to transplant
Damage done by the immune system to a transplanted organ
Define autologous transplant
Tissue returning to the same individual after a periods outside the body
Define syngeneic transplant/ isograft
Transplant between identical twins
Normally no problem with graft reflection
Define allogeneic transplant
Between genetically non identical members of the same species
Define cadaveric transplant
Use organs from dead donors
Define xenogeneic transplant
Takes place between different species and carriers the highest risk of rejection
Solid organ transplant criteria
Good evidence damage is irreversible
That alternative treatments are not applicable
Disease must not recur
How to minimise the rejection chances of transplant
Donor and recipient must be ABO compatible
Recipient must not have anti-donor human leukocyte antigen antibodies
Close as possible HLA match to recipient
Patient must take immunosuppressive treatment
What is a hyperacute rejection
Within hours Preformed antibodies binding to either ABO blood groups or HLA class I antigens on graft
Antibody binding triggers a type II hypersensitivity reaction and the graft is destroyed by vascular thrombosis
Type of hypersensitivity reaction of hyperacute rejection
Type 2
Type of hypersensitivity reaction of acute rejection
4
Describe acute rejection
Delayed
Takes place within days or weeks of transplant
Donor dendritic cells stimulate an allogeneic response in a local lymph node and T cells proliferate and migrate into donor kidney
HLA incompatibility is the main cause
What is a chronic rejection with regards to transplant
Takes months or years
An element of allogeneic reaction is often mediated by T cells, which can result in repeated acute rejection
May be caused by recurrence of pre-existing autoimmune disease
Describe immunosuppressive drugs
Prevent rejection until stopped
Also lack specificity of true tolerance and thus prevent immune response to infectious agents
Immunopathology of graft rejection
Afferent phase:
MHC molecules recognised by CD4+ T cells (allorecognition)
Effector phase:
CD4+ T cells recruit effector cells responsible for the tissue damage of rejection: macrophages, CD8+ T cells, NK cells and B lymphocytes